Germany, Genetics
Resilient seeds - Nurturing the future of agriculture
Resilient seeds - Nurturing the future of agriculture For the first time in its history, the Global Seed Vault on the Svalbard Islands, Norway, has authorised a withdrawal. It was requested in 2015 by Syria, a country where the war is endangering the local agricultural seed collections.
Twins help progress and diagnosis of rare Myasthenia
Twins help progress and diagnosis of rare Myasthenia Fourteen pairs of identical twins joined the EU funded medical project “ Fight-MG ”, to fight Myasthenia Gravis . This rare autoimmune disease leads to abnormal fatigability of various skeletal muscles.
Sonia Aknin-Berrih: How rare models suggest new treatment strategies
Sonia Aknin-Berrih: How rare models suggest new treatment strategies Myasthenia Gravis (MG) is a rare auto-immune disease—whereby patients’ immune systems attack their own bodies— arising from a breakdown in communications between the nervous and muscular systems.
Network of experts join forces to fight rare disease
Network of experts join forces to fight rare disease Collaboration between research groups is key in tackling rare diseases such as auto-immune disease Myasthenia Gravis (MG). Indeed, the rarity of the disease means that it can be difficult to collect enough samples of blood and tissues to perform quality research.
Secrets of youth, based on prevention
Secrets of youth, based on prevention We age in two ways. There is the ageing we count by clock and calendar. And then there is biological ageing. The latter is written into our genes. But, it is also influenced by our lifestyle and history.
Human Bones from the Lab
Human Bones from the Lab Scientists in Würzburg, in Germany, have created living bone material from human stem cells in their laboratory. The discipline is called tissue engineering and the aim of the scientists is to produce the perfect substitute for bone transplantation.
Healing bone defects using regenerative medicine
Healing bone defects using regenerative medicine Bone is one of the most frequently transplanted tissues. And the demand is rising. Transplants treat large defects like those caused by trauma, complicated fractures, tumour resection or osteoporosis. ...
Heike Walles – A diverse toolbox for regenerating bones
Heike Walles – A diverse toolbox for regenerating bones Bone grafts are among the most sought after tissue transplants in clinical practice. And this demand is expected to rise due to an ageing population.
Proteins: The Key for all Diseases?
Proteins: The Key for all Diseases? The impact if this challenge could be huge, as this set of data could l ead to new therapies and diagnosing tools for virtually all diseases , including diabetes or cancer.  Proteins are everywhere.
Mapping proteins in space and time within cells
Mapping proteins in space and time within cells The human genome and those of several other organisms have been mapped. But it is proteins that perform the majority of biological functions within every organism .
New therapy against rare gene defects
New therapy against rare gene defects European scientists set up new therapeutic approaches to tackle specific Lysosomal Storage Disorders: a new drug combination and enzyme replacement therapy against Pompe disease and gene therapy against MPS V I (Mucopolysaccharidosis VI).
Cow fertility – not so black and white
Cow fertility – not so black and white Holstein cattle - the black-and-white dairy cows you might see in a child’s picture book - have been bred in northern Europe for hundreds of years.
Smart and personal: dietary advice
Smart and personal: dietary advice After personalised medicine, we are entering the era of personalised nutrition. But this approach requires testing before being applicable. This is what a new EU-funded research project, called food4me , is attempting to do.
Metagenomics: hunting for new genes by sequencing seas samples
Metagenomics: hunting for new genes by sequencing seas samples One litre of sea water contains about one billion bacteria.
Prof. Thomas Klockgether: "Ataxia-sufferers are placing their hopes in research"
Prof. Thomas Klockgether: "Ataxia-sufferers are placing their hopes in research" With a prevalence of about 1 in 10.000, Ataxia is considered a rare hereditary disease that attacks the central nervous system. As a result, it is not at the top of the list in terms of research topics for pharmaceutical companies.
Genes out of Balance
Genes out of Balance For a neurodegenerative disease that strikes later in life with neuronal dysfunction and subsequent cell death by showing a mind-boggling heterogeneity of subtypes, spinocerebellar ataxia had not been adequately tackled for a long time.